Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Recruiting now · Phase 4

Conditions studied: Cirrhosis, HCC - Hepatocellular Carcinoma, Portal Vein Thrombosis

In brief

We will give an anticoagulant against portal vein thrombosis, and watch for the results.

Key facts

Study ID

NCT07132515

Run by

Mansoura University

People needed

100

Starts

2023-08-15

Expected to finish

2025-08-01

Last updated by the study team

2025-08-20

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Portal vein thrombosis, Cirrhosis, With or without HCC, Child A \& B

You may not qualify if…

• Platelets<10000, Createnine >1.9, Budd ciarri, Uncontrolled active bleeding

Where it is running

• Mansoura University Hospitals — Al Mansurah, Dakahlia Governorate, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.